Most important, the SR-B2/CD36 receptor is the primary regulator of NOD-like receptor (NLR) protein inflammasome 3 (NLRP3) signaling activation (see Figure 2 and further on) in AD, atherosclerosis, and type-2 diabetes. The gene discussed is MED20; the disease is Alzheimer disease.